Can semaglutide cause headaches?

This site's semaglutide citation findings do not report headache as a counted trial outcome. They report gastrointestinal adverse events in OASIS 4 (74.0% versus 42.2% on placebo), dysesthesia in 22.9% on the 7.2 milligram dose in STEP UP, and the weight and heart results already on the semaglutide page (STEP 1: 1,961 adults, minus 14.9% at 68 weeks; SELECT: 17,604 adults, mean 39.8 months, 20% fewer major events). Headache is not given a percentage here. This FAQ does not invent an adverse-event rate the citations do not contain.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of more absences and national fields. Further harvested questions after the first names-and-absences set: more side effects the citations did not count, compounding formulas this catalogue does not hold, national legal-status fields for compounds that only have those four countries, trial windows rather than an onset clock, and named prescription combinations with no interaction table.